These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1073 related items for PubMed ID: 16155434

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
    Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, Beeson D, Willcox N, Vincent A.
    Brain; 2008 Jul; 131(Pt 7):1940-52. PubMed ID: 18515870
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R, Hilton-Jones D, Matthews PM, Vincent A.
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [Abstract] [Full Text] [Related]

  • 6. Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.
    Hurst RL, Gooch CL.
    Curr Neurol Neurosci Rep; 2016 Jul; 16(7):61. PubMed ID: 27170368
    [Abstract] [Full Text] [Related]

  • 7. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN, Reddel SW, Gervásio OL, Phillips WD.
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG, Sidnev DV, Karganov MIu.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010 Jun; 110(12):72-6. PubMed ID: 21311492
    [Abstract] [Full Text] [Related]

  • 13. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E.
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [Abstract] [Full Text] [Related]

  • 14. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
    Koneczny I, Cossins J, Vincent A.
    J Anat; 2014 Jan; 224(1):29-35. PubMed ID: 23458718
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A, Djukic P, Basta I, Hajdukovic Lj, Stojanovic VR, Stevic Z, Nikolic D, Bozic V, Lavrnic S, Lavrnic D.
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L, Ranelletti F, Maggiano N, Guerriero M, Punzi C, Marsili F, Bartoccioni E, Evoli A.
    Neurology; 2005 Feb 08; 64(3):536-8. PubMed ID: 15699390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.